Israel Corporation reported $645M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Avient USD 425.6M 2M Jun/2026
Chemours USD 671M 108M Jun/2026
Corteva USD 2.37B 401M Jun/2026
ICL Group USD 407M 116M Mar/2026
Israel Corporation USD 645M 219M Mar/2026
PhosAgro RUB 13.36B 93.57B Dec/2022
UPL INR 59.75B 18.23B Mar/2026